Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$32.38 USD
-0.65 (-1.97%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $32.41 +0.03 (0.09%) 7:26 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.89 |
EPS Last Quarter | -0.88 |
Last EPS Surprise | 10.20% |
ABR | 1.22 |
Earnings ESP
|
-2.63% |
---|---|
Current Year | -3.68 |
Next Year | -2.30 |
EPS (TTM) | -4.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 42.32M | 50.66M | 158.53M | 283.42M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 45.00M | 55.28M | 166.70M | 323.70M |
Low Estimate | 39.07M | 45.85M | 144.61M | 258.31M |
Year ago Sales | 1.87M | 13.08M | 17.45M | 158.53M |
Year over Year Growth Est. | 2,162.83% | 287.29% | 808.61% | 78.79% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.89 | -0.90 | -3.68 | -2.30 |
# of Estimates | 6 | 5 | 6 | 5 |
Most Recent Consensus | -0.89 | -0.90 | -3.70 | -1.40 |
High Estimate | -0.78 | -0.79 | -3.39 | -1.40 |
Low Estimate | -0.98 | -1.04 | -3.91 | -3.90 |
Year ago EPS | -1.28 | -1.31 | -4.62 | -3.68 |
Year over Year Growth Est. | 30.47% | 31.30% | 20.35% | 37.55% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.89 | -0.90 | -3.68 | -2.30 |
7 Days Ago | -0.89 | -0.90 | -3.68 | -2.30 |
30 Days Ago | -0.89 | -0.90 | -3.68 | -2.30 |
60 Days Ago | -0.91 | -0.89 | -3.73 | -2.15 |
90 Days Ago | -0.91 | -0.89 | -3.75 | -2.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.91 | -0.88 | -3.68 | -1.63 |
Zacks Consensus Estimate | -0.89 | -0.90 | -3.68 | -2.30 |
Earnings ESP | -2.63% | 1.79% | 0.00% | 29.07% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.88 | -1.01 | -1.31 | -1.28 | NA |
Estimate | -0.98 | -1.15 | -1.37 | -1.40 | NA |
Difference | 0.10 | 0.14 | 0.06 | 0.12 | 0.11 |
Surprise | 10.20% | 12.17% | 4.38% | 8.57% | 8.83% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more